Literature DB >> 17883392

The effects of oxidative stress on parkin and other E3 ligases.

Matthew J LaVoie1, Giuseppe P Cortese, Beth L Ostaszewski, Michael G Schlossmacher.   

Abstract

Autosomal recessive mutations within the Parkin gene are associated with degeneration of the substantia nigra and locus coeruleus and an inherited form of Parkinson's disease (PD). As loss-of-function mutations in parkin are responsible for a familial variant of PD, conditions that affect wild-type parkin are likely to be associated with increased risk of idiopathic disease. Previous studies uncovered a unique vulnerability of the parkin protein to dopamine (DA)-induced aggregation and inactivation. In this study, we compared several proteins that share structural elements or ubiquitinating activity with parkin. We report that oxidative stress in several cell lines and primary neurons induces the aggregation of parkin into high molecular weight species, at least a portion of which are self-associated homo-multimers. While parkin was preferentially affected by excess DA, each of the E3 proteins tested were made more insoluble by oxidative stress, and they varied in degree of susceptibility (e.g. parkin > HHARI congruent with CHIP > c-Cbl > E6AP). These conditions of oxidative stress were also associated with decreased parkin E3 ligase activity. Similar to recently conducted studies on alpha-synuclein processing, both macroautophagy and the proteasome participate in parkin degradation, with the proteasome playing the predominant role for normal parkin turnover and macroautophagy being more important in the degradation of aggregated parkin. These data further highlight the selective vulnerability of parkin to DA-induced modifications, demonstrating for the first time the ability of both endogenous and ectopically expressed parkin to transition into an insoluble state in part through self-association and oligomer formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883392     DOI: 10.1111/j.1471-4159.2007.04911.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 2.  Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.

Authors:  Zezong Gu; Tomohiro Nakamura; Stuart A Lipton
Journal:  Mol Neurobiol       Date:  2010-03-25       Impact factor: 5.590

Review 3.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

4.  Self-administration of methamphetamine alters gut biomarkers of toxicity.

Authors:  Amanda Flack; Amanda L Persons; Sharanya M Kousik; T Celeste Napier; Anna Moszczynska
Journal:  Eur J Neurosci       Date:  2017-08       Impact factor: 3.386

Review 5.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

6.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 7.  Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

8.  Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.

Authors:  Shan Yan; Xuxu Sun; Binggang Xiang; Hui Cang; Xunlei Kang; Yuying Chen; Hui Li; Guiying Shi; Edward T H Yeh; Beilei Wang; Xiangrui Wang; Jing Yi
Journal:  EMBO J       Date:  2010-10-05       Impact factor: 11.598

Review 9.  An emerging role of PARK2 in cancer.

Authors:  Liang Xu; De-chen Lin; Dong Yin; H Phillip Koeffler
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

10.  Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.

Authors:  Kenneth M Rosen; Charbel E-H Moussa; Han-Kyu Lee; Pravir Kumar; Tohru Kitada; Gangjian Qin; Qinghao Fu; Henry W Querfurth
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.